JPMorgan Plans to Buy 100% Stake in Futures JV in ChinaHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)JPMorgan Plans to Buy 100% Stake in Futures JV in ChinaZacks Equity ResearchZacksJanuary 2, 2020ReblogShareTweetShareAs China opens its financial markets to foreign firms, JPMorgan JPM seeks to eventually own 100% in its futures joint venture (JV) – J.P.Morgan Futures Co. This was first reported by Bloomberg earlier this week.Notably, the limits on foreign ownership of futures business got scrapped on Jan 1 as part of China’s efforts to gradually open up financial sector to overseas players. Apart from futures business, insurance industry opened up for foreign firms for majority stake.At present, JPMorgan has 49% stake in the JV, which was formed in 2007. Per the filings with the China Securities Regulatory Commission, the bank has applied for shareholding pattern change and seeks to buy more than a 5% stake in the JV.If approved, JPMorgan will become the first foreign firm to have a majority ownership of its Chinese futures operation. China’s futures markets, dominated by approximately 150 domestic players, had transactions worth almost $30 trillion in 2019. Thus, this will open up a huge market for the bank.  Earlier in December, JPMorgan finally received regulatory approval to set up a majority-owned securities JV in China. Also, in August 2019, the company won a 2% stake to gain controlling interest in its China fund management JV in an auction at the Shanghai United Assets and Equity Exchange. The deal is still subject to regulatory approval.Shares of JPMorgan rallied 42.8% in 2019, outperforming the industry’s rise of 35.2%.Currently, JPMorgan carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Other than JPMorgan, several major global financial firms like Goldman Sachs GS, Nomura Holdings, Morgan Stanley MS, BlackRock BLK and UBS Group have won approval or are waiting for the same to increase stakes in their respective JVs in China. Thus, once foreign companies are allowed to conduct business in the country without any restrictions, it will help in geographical expansion and boost revenues.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.See 7 handpicked stocks now >>Click to get this free reportJPMorgan Chase & Co. (JPM) : Free Stock Analysis ReportMorgan Stanley (MS) : Free Stock Analysis ReportThe Goldman Sachs Group, Inc. (GS) : Free Stock Analysis ReportBlackRock, Inc. (BLK) : Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextGlobal coronavirus cases rise as China’s downward trend continuesPA Media: World NewsKorea Cases Top 2,000; WHO Sees ‘Decisive’ Stage: Virus UpdateBloombergHow investors are using ‘alternative’ data to track China’s recovery from coronaviruMarketWatchWorld prepares for coronavirus pandemic; global recession forecastReutersOPEC Chief Says Group Is Making Renewed Push for Oil DealBloombergRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoHow Does China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512) Stand Up To These Simple Dividend Safety Checks?Simply Wall St.Most face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video